Ropes & Gray is home to one of the world's preeminent life sciences groups, with a global platform for innovators at every stage of the development lifecycle. Our collaborative approach spanning more than 25 practice areas offers one of the largest and most experienced industry-specific teams, comprised of more than 300+ lawyers and specialists who deliver sophisticated transactional, regulatory, IP, litigation and enforcement strategies to position industry innovators and investors for success.

Counting the top 10 largest global biopharmaceutical companies and the top 10 largest global medical device companies as clients, Ropes & Gray is sought after by the biggest players for our deep industry-specific knowledge across every life sciences category. In the past year, we have advised major names such as AstraZeneca, Blackstone Life Sciences, Bain Capital, Becton Dickinson, Bristol Myers Squibb, Convatec, Eli Lilly, GE Healthcare, Novo Nordisk, Pfizer, Regeneron, Takeda and more.